Switzerland approves Pfizer booster for over-16s

The Swiss Agency for Therapeutic Products (Swissmedic) approved on Tuesday the use of the Pfizer/BioNTech booster vaccine for the population aged 16 and over. The shot can also be given to at-risk peo…